Oracle (ORCL) March 114 straddle into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Oracle (ORCL) PT Raised to $142 at CFRA
March 12, 2024 9:30 AM EDTCFRA analyst Angelo Zino raised the price target on Oracle (NYSE: ORCL) to $142.00 (from $130.00) while maintaining a Hold rating.
The analyst comments "We increase our 12-month target to $142 from $130, on a higher revised P/E of 21x our CY 25 EPS estimate of... More
Oracle (ORCL) PT Raised to $145 at TD Cowen
March 12, 2024 6:39 AM EDTTD Cowen analyst Derrick Wood raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "ORCL reported a solid 3Q w/ total rev growth of 7% cc in line w/ guide of 6-8%, incl.... More
Oracle (ORCL) PT Raised to $145 at Evercore ISI, 'Outlook Less Cloudy'
March 12, 2024 5:02 AM EDTEvercore ISI analyst Kirk Materne raised the price target on Oracle (NYSE: ORCL) to $145.00 (from $130.00) while maintaining a Outperform rating.
The analyst comments "Bottom line: Oracle shares are up nicely in the after-market as OCI revenue growth of 52% in c/c was in line with our expectations and importantly, F4Q guidance infers OCI growth of ~40% against a very difficult compare. The other highlight was the strength in RPO, which grew 41% in c/c excl. Cerner to $80bn and cRPO growth of ~15%. Notably, OCI revenue grew $175mn sequentially vs. $100mn last quarter.... More
Oracle (ORCL) PT Raised to $150 at Jefferies, 'F3Q: Base Hit, One Runner On'
March 12, 2024 5:01 AM EDTJefferies analyst Brent Thill raised the price target on Oracle (NYSE: ORCL) to $150.00 (from $145.00) while maintaining a Buy rating.
The analyst comments "ORCL made contact in F3Q after a disappointing F1H led by better-than-expected OCI results and 29% backlog growth. While... More
